1. Home
  2. GTN vs ASMB Comparison

GTN vs ASMB Comparison

Compare GTN & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gray Television Inc.

GTN

Gray Television Inc.

N/A

Current Price

$5.04

Market Cap

452.2M

Sector

Industrials

ML Signal

N/A

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

N/A

Current Price

$29.39

Market Cap

440.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GTN
ASMB
Founded
1897
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
452.2M
440.0M
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
GTN
ASMB
Price
$5.04
$29.39
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
6
Target Price
$8.50
$43.40
AVG Volume (30 Days)
1.5M
93.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
5.94%
N/A
EPS Growth
N/A
50.00
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$13.44
$33.33
Revenue Next Year
N/A
N/A
P/E Ratio
$11.72
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.13
$7.76
52 Week High
$6.31
$39.71

Technical Indicators

Market Signals
Indicator
GTN
ASMB
Relative Strength Index (RSI) 51.41 51.72
Support Level $4.42 $26.50
Resistance Level $5.35 $31.11
Average True Range (ATR) 0.40 1.78
MACD 0.02 0.11
Stochastic Oscillator 36.59 68.78

Price Performance

Historical Comparison
GTN
ASMB

About GTN Gray Television Inc.

Gray Media Inc is a multimedia company. The company owns and operates local television stations and digital assets. It also owns Gray Digital Media, a full-service digital agency offering national and local clients digital marketing strategies with digital products and services. Its additional media properties include video production companies Raycom Sports, Tupelo Media Group, and PowerNation Studios, and studio production facilities Assembly Atlanta and Third Rail Studios.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Share on Social Networks: